ConductScience.org, home

Paper · 33239267

Artificial Intelligence Predicts Drug Response.

Cancer Discov, 2021. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Artificial Intelligence Predicts Drug Response. Papers, record 33239267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33239267

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Artificial Intelligence Predicts Drug Response.
PubMed
Journal
Cancer Discov
PubMed
Year
2021
PubMed
Publication types
News, Comment
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2021-06-04
PubMed

Authors0

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

None in this release.

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Deep LearningMajor topic
NeoplasmsMajor topic
Pharmaceutical PreparationsMajor topic
Artificial Intelligence
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on33,096,023Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.https://conductscience.org/library/papers/33096023

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41,963,934Application of artificial intelligence in lung cancer diagnosis, therapy, and prognosis.BMC Med Genomics2026https://conductscience.org/library/papers/41963934PubMed
41,718,388Bridging the Gap Between Static Histology and Dynamic Organ-on-a-Chip Models.Pathophysiology2026https://conductscience.org/library/papers/41718388PubMed
38,506,918Preliminary Evidence of the Use of Generative AI in Health Care Clinical Services: Systematic Narrative Review.JMIR Med Inform2024https://conductscience.org/library/papers/38506918PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33239267

GET https://conductscience.org/api/papers/v1/33239267/authors